Britain prepares for Covid-19 vaccine as Oxford forecasts 2020 results
Baker Hughes Snaps Up Compact Carbon Capture For Energy Transition Path
Google crushes Wall Street earnings expectations, but there is a grain of salt…
Regeneron, Lilly Setbacks Raise Questions on the Effectiveness of Antibodies in Severe COVID-19
David Einhorn Made 7.7% In Month He Claims "Enormous" Tech Bubble Popped
Is Boeing Stock a Buy Following Q3 Earnings? Analyst Weighs In
Moderna banks $1.1bn in COVID-19 vaccine deposits, signs Japan supply deal
Healthcare And Biotech Outlook –Final Quarter of 2020
Shopify stock is up in pre-market trading as earnings blow past estimates
AMZN, AAPL, GOOGL and FB report earnings on Thursday – what should we expect?
Sanofi, GSK Ink Covax Supply Deal For 200M Covid Vaccine Doses
Eli Lilly Ends Covid-19 Trial In Hospitalized Patients On Disappointing Data
Moderna nears COVID-19 vaccine finish line as it wraps up study enrolment
J&J Prepares To Restart US Covid-19 Vaccine Trial Recruitment
Recent College Grads Face Worst Employment Prospects In Decades Thanks To COVID-19
FDA Approves Gilead's Remdesivir To Treat COVID-19 Despite Data Showing Drug Doesn't Work
Exclusive: Eyeing big Covid-19 testing expansion, Ginkgo rolls out 50M rapid antigen diagnostics
AZ’s COVID-19 vaccine trial ready to resume in US – reports
UK government signs contract for COVID-19 challenge trial
United Airlines Adds 8 New Routes To Boost Latin America Presence
Goldman Sachs: 2 Stocks That Could Climb Over 90%
Top Analysts Pound the Table on These 3 Stocks
U.S. coronavirus cases surpass eight million as infections spike nationwide
"Temporary" Layoffs Turning Into Permanent Job Losses
BioNTech: COVID-19 Vaccine Submissions Initiated, But This Analyst Still Says Hold Off
Delta Sinks On Huge Q3 Loss As Covid-19 Hurts Travel Demand
Johnson & Johnson Covid-19 Vaccine Trial Halted
Q3 Earnings Preview: It's The FAAMGs Vs Everyone Else
Remdesivir study finally published – an expert in critical care medicine gives us his verdict
AstraZeneca Inks $486M US Support For Covid-19 Antibody Cocktail